Sildenafil Teva
From £3.99
Clinical Evidence and Safety Research
Extensive Clinical Trial Data
Viagra (sildenafil) has undergone rigorous clinical testing involving thousands of participants across multiple studies. The landmark trials that led to its approval included over 4,000 men with erectile dysfunction of various causes. These studies demonstrated that sildenafil was effective in approximately 70-80% of participants, with improvements in erectile function measured using validated assessment tools. The same active ingredient is found in generic sildenafil, offering patients an identical treatment option at a lower cost.
Cardiovascular Safety Profile
One of the most important safety considerations surrounds cardiovascular effects. Research published in the American Journal of Cardiology found that sildenafil causes only mild, temporary reductions in blood pressure in healthy individuals. However, dangerous interactions can occur with nitrate medications commonly prescribed for chest pain. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) requires comprehensive cardiovascular assessment before prescribing. Studies show that men with stable cardiovascular disease can often use sildenafil safely under medical supervision.
Common Side Effects and Frequency
Clinical trials reveal that most side effects are mild and resolve naturally. Headaches occur in approximately 16% of users, facial flushing in 10%, and nasal congestion in 4%. These effects typically diminish as the body adjusts to treatment. Serious adverse events are rare, occurring in less than 2% of patients in clinical studies. The safety profile remains consistent whether patients choose branded Viagra or generic sildenafil.
Long-term Safety Data
Post-marketing surveillance covering millions of prescriptions has provided valuable long-term safety insights. A comprehensive review published in the International Journal of Impotence Research analysed data from over 25 years of use, confirming the medication's safety when prescribed appropriately. The study found no evidence of tolerance development or increased risk of serious adverse events with prolonged use. Regular medical review ensures continued suitability for treatment.
Special Population Studies
Research has examined sildenafil safety in specific groups, including men with diabetes, prostate surgery history, and mild cardiovascular disease. Studies demonstrate maintained safety profiles in these populations when proper medical assessment occurs. However, certain conditions require dose adjustments or additional monitoring. EverydayMeds' clinical team evaluates individual medical history to ensure appropriate prescribing for each patient's circumstances.
Contraindications and Risk Management
While generally safe, sildenafil has absolute contraindications that medical research has identified. The most significant involves nitrate medications, where combination use can cause dangerous blood pressure drops. Studies also highlight increased risks for men with severe heart disease, recent stroke, or significant liver impairment. Proper medical screening identifies these risk factors before prescribing, ensuring patient safety remains the priority throughout treatment.
